Parkinson’s disease is a progressive neurological condition that affects movement and can lead to tremors, muscle stiffness and slowed actions.
While there’s no cure, various treatments aim to manage symptoms and improve quality of life. Medical cannabis can be explored as a potential option for managing motor and non-motor symptoms of Parkinson’s disease when other treatments have not provided symptom relief.
Parkinson’s disease is a condition of the brain that causes a resting tremor which is typically worse in one side compared to the other. It is a neurodegenerative disease for which there is no cure and typically increases in severity with time. Currently available medications which target dopaminergic pathways (a pathway in the brain where the predominant signalling molecule is dopamine) have been a success for Parkinson’s disease treatment. However, some patients are affected by treatment-resistant motor symptoms, treatment induced movement disorders, and non-motor symptoms for which there are limited therapeutic options.
Parkinson’s disease is most common in adult males over the age of 50 and globally the number of individuals with Parkinson’s disease is estimated to double between 2005 to 2030.
The exact cause of Parkinson’s is unknown but the disease is defined by a loss of dopaminergic (or dopamine containing) nerve cells in the substantia nigra part of the brain. The substantia nigra is a part of a group of structures called the basal ganglia, which play an essential role in the co-ordination of movement.
In addition, people with Parkinson’s disease also contain abnormal build-up of protein in structures called Lewy bodies.
Whilst it is more common in people over the age of 50, there are cases of people under 50 being diagnosed with Parkinson’s disease.
Parkinson’s symptoms may start off mild and often begin with resting tremors of the hands. Typically symptoms are worse on one side compared to the other. Additional Parkinson’s disease symptoms may follow later including:
Parkinson’s disease diagnosis is given based upon symptoms, medical history, and full physical examination carried out by a healthcare professional; there isn’t a test for the disease. It can be hard to diagnose at the onset as early signs of Parkinson’s disease are normally very mild.
For those with atypical features of Parkinson’s Plus syndromes MRI brain and functional neuroimaging may be performed.
Day-to-day life with Parkinson’s disease may be challenging, particularly in advanced stages. Medical cannabis may be appropriate for some patients as part of a wider treatment plan, to address related tremors, anxiety, pain and sleep quality.
View our FAQ’s section and learn more about all the conditions that can be treatable with medical cannabis.